Jushi Holdings Inc. announced today that the DEA has granted registrations for its state‑licensed medical marijuana operations, marking a major regulatory win. It signals a decisive step toward federal alignment for medical cannabis.
Regulatory Milestone
The registrations follow the Attorney General’s April 2026 order that rescheduled qualifying medical cannabis to Schedule III and created a federal framework for eligible operators. The move clears a path for companies like Jushi to operate under a unified federal regime.
Company Overview
Jushi Holdings is a vertically integrated cannabis firm focused on building a multi‑state portfolio through strategic acquisitions and organic growth. It aims to maximize shareholder value while delivering high‑quality products across the cannabis ecosystem.
Forward-Looking Information
The press release contains forward‑looking statements about future business strategy, expansion, financing and regulatory developments, based on current expectations and assumptions. These statements reflect risks and uncertainties, including the company’s ability to continue as a going concern, market competition, operational execution and regulatory changes.
Contact
For investor inquiries, contact Jushi Investor Relations: Trent Woloveck, Co‑Chief Strategy Director, 614‑271‑4349, trent@jushico.com, investors@jushico.com. The team is available to answer questions about the company’s regulatory milestones and growth plans.
